The launch of this new point-of-care analyzer automates cytology and blood cell morphology, representing a significant investment in AI, advanced optics, and cloud-integrated hardware.
Filing excerpt
Beginning in late 2024 we launched our point-of-care cellular analyzer, IDEXX inVue Dx, which automates real-time cytology and blood cell morphology testing.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kproductLaunchGet every 10-K signal for Idexx Laboratories and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Idexx Laboratories this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/aa30b9e7-6b26-4c36-b8ec-d6b0a65d0dab returns this record as JSON. POST /v1/companies/enrich returns every signal for idexx.com.
{
"signal_id": "aa30b9e7-6b26-4c36-b8ec-d6b0a65d0dab",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-24T09:21:44.135+00:00",
"company": {
"name": "Idexx Laboratories",
"domain": "idexx.com"
},
"data": {
"detail": "The launch of this new point-of-care analyzer automates cytology and blood cell morphology, representing a significant investment in AI, advanced optics, and cloud-integrated hardware. This creates opportunities for vendors supporting new product introductions and advanced technology manufacturing.",
"summary": "Launched AI-powered IDEXX inVue Dx cellular analyzer in late 2024",
"excerpts": "Beginning in late 2024 we launched our point-of-care cellular analyzer, IDEXX inVue Dx, which automates real-time cytology and blood cell morphology testing.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/874716/000087471626000038/idxx-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"technologies_mentioned": [
"AI",
"cloud"
]
}
}
curl https://signals.autobound.ai/v1/signals/aa30b9e7-6b26-4c36-b8ec-d6b0a65d0dab \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.